Our findings demonstrate that CMT patients showed significantly reduced levels of circulating irisin compared to controls (6.51 ± 2.26 vs 9.34 ± 3.23 μg/ml; p=0.003) (Figure 1). The gene discussed is FNDC5; the disease is Charcot-Marie-Tooth disease.